These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 15148534

  • 1. Enfuvirtide.
    Lalezari JP, Luber AD.
    Drugs Today (Barc); 2004 Mar; 40(3):259-69. PubMed ID: 15148534
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical efficacy and tolerance of enfuvirtide (Fuzeon), new antiretroviral inhibitors of intracellular penetration of human immunodeficiency virus (HIV) type 1].
    Raffi F.
    Med Mal Infect; 2004 Sep; 34 Spec No 1():8-17. PubMed ID: 15742550
    [Abstract] [Full Text] [Related]

  • 4. [Enfuvirtide, mechanism of action and pharmacological properties].
    Kapić E, Becić F, Zvizdić S.
    Med Arh; 2005 Sep; 59(5):313-6. PubMed ID: 16134757
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enfuvirtide: first fusion inhibitor for treatment of HIV infection.
    Jamjian MC, McNicholl IR.
    Am J Health Syst Pharm; 2004 Jun 15; 61(12):1242-7. PubMed ID: 15259753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enfuvirtide: a fusion inhibitor for the treatment of HIV infection.
    Fung HB, Guo Y.
    Clin Ther; 2004 Mar 15; 26(3):352-78. PubMed ID: 15110129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resistance to enfuvirtide, the first HIV fusion inhibitor.
    Greenberg ML, Cammack N.
    J Antimicrob Chemother; 2004 Aug 15; 54(2):333-40. PubMed ID: 15231762
    [Abstract] [Full Text] [Related]

  • 13. A controlled Phase II trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults.
    Lalezari JP, DeJesus E, Northfelt DW, Richmond G, Wolfe P, Haubrich R, Henry D, Powderly W, Becker S, Thompson M, Valentine F, Wright D, Carlson M, Riddler S, Haas FF, DeMasi R, Sista PR, Salgo M, Delehanty J.
    Antivir Ther; 2003 Aug 15; 8(4):279-87. PubMed ID: 14518696
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enfuvirtide (T-20): a novel human immunodeficiency virus type 1 fusion inhibitor.
    Cervia JS, Smith MA.
    Clin Infect Dis; 2003 Oct 15; 37(8):1102-6. PubMed ID: 14523775
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reassessment of enfuvirtide's role in the management of HIV-1 infection.
    Marr P, Walmsley S.
    Expert Opin Pharmacother; 2008 Sep 15; 9(13):2349-62. PubMed ID: 18710359
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enfuvirtide: a review of its use in the management of HIV infection.
    Oldfield V, Keating GM, Plosker G.
    Drugs; 2005 Sep 15; 65(8):1139-60. PubMed ID: 15907147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.